samedan logo
 
 
spacer
home > ebr > autumn 2001 > distribution of temperature-sensitive products - when time is more than just money
PUBLICATIONS
European BioPharmaceutical Review

Distribution of Temperature-Sensitive Products - When Time is More than Just Money

Pharmaceutical Exports

The latest figures available from the Association of the British Pharmaceutical Industry put the value of UK pharmaceutical exports at £5.5 billion, making it one of the country's biggest international trade success stories and putting pharmaceutical exports at the heart of the knowledge-based economy. Furthermore, five of the world's top 20 medicines were developed in British laboratories.Nevertheless, whilst the worldwide health care market continues to soar, established pharmaceutical manufacturers face challenges on all fronts. The past is no longer a guide for the future, and blockbuster products are increasingly more difficult and costly to find. So what are these fundamental changes that are currently reshaping the pharmaceutical industry? Change is never from one source but comes about when a variety of factors begin to emerge.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

By Mario Johnson, Pharmaceutical Industry Manager for DHL International (UK) Ltd 
A Business Studies Graduate from the Buckinghamshire Management College, Mario Johnson is the Pharmaceutical Industry Manager for DHL International (UK) Ltd. Mario joined DHL in 1993 and went on to become a Business Development Manager, first for DHL North East Region, and then for the Central Logistics Department.
In his role as Pharmaceutical Industry Manager, Mario works alongside a team of key account managers and is responsible for developing and implementing state-of-the-art delivery solutions.

spacer
Mario Johnson
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

4th Annual Patient Recruitment and Retention in Clinical Trials

13-15 October 2008, Amsterdam

Patient recruitment is now consuming thirty percent of clinical trial time - more time than any other clinical trial activity - and almost half of all trial delays result from patient recruitment problems. As the recruiting culture becomes more sophisticated and the forces affecting patient enrollment grow more numerous and complex, pharmaceutical companies are striving to discover new strategies to facilitate enrollment in clinical trials. With increasing industry pressure to develop, test and market greater numbers of new drugs faster, pharmaceutical companies need to perform clinical trials as quickly as possible. Inefficient patient recruitment processes is a formidable barrier to pharmaceutical companies' success in launching new products. Improving the patient recruitment process is imperative to avoid wasted investments and eliminate costly delays in bringing new drugs to market -- today and even more so in the not-so-distant future. Improved patient recruitment presents one of the largest opportunities for pharmaceutical companies to eliminate delays in clinical trials, thereby making it possible to reduce time to market.  With patent time limits and large overheads meaning that any delays in the development timeline can be disastrous, a good understanding of how to successfully recruit patients for trials is vital for any company looking to succeed.
More info >>

 
News and Press Releases

“PACK DIFFERENT” with EMBALLAGE 2008

“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement